FRISO, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 8.616
EU - Europa 7.064
AS - Asia 1.998
SA - Sud America 27
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 8
Totale 17.750
Nazione #
US - Stati Uniti d'America 8.585
GB - Regno Unito 2.948
CN - Cina 1.611
FR - Francia 745
DE - Germania 744
SE - Svezia 716
IE - Irlanda 595
FI - Finlandia 515
IT - Italia 449
VN - Vietnam 179
UA - Ucraina 165
TR - Turchia 84
BE - Belgio 67
KR - Corea 45
RU - Federazione Russa 41
CA - Canada 24
NL - Olanda 19
AU - Australia 18
IN - India 18
EU - Europa 15
BR - Brasile 12
IR - Iran 10
CL - Cile 8
ES - Italia 8
IL - Israele 8
RO - Romania 8
EG - Egitto 6
HR - Croazia 6
JP - Giappone 6
CZ - Repubblica Ceca 5
LU - Lussemburgo 5
SG - Singapore 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
HK - Hong Kong 4
LT - Lituania 4
MX - Messico 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
AT - Austria 3
AZ - Azerbaigian 3
CH - Svizzera 3
DK - Danimarca 3
PL - Polonia 3
IQ - Iraq 2
LV - Lettonia 2
PK - Pakistan 2
SA - Arabia Saudita 2
AM - Armenia 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
SI - Slovenia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 17.750
Città #
Southend 2.643
Jacksonville 1.669
Chandler 1.431
Woodbridge 1.094
Ann Arbor 822
Dublin 593
Houston 507
Ashburn 478
Wilmington 271
New York 254
Lawrence 248
Princeton 248
Beijing 221
Nanjing 181
Verona 180
Jinan 172
Dong Ket 170
Shenyang 127
Sindelfingen 101
Helsinki 93
Hebei 88
Tianjin 85
Lancaster 77
Nanchang 71
Brussels 67
Changsha 67
Zhengzhou 65
Milan 57
Haikou 56
Boardman 55
Redmond 54
Ningbo 51
Jiaxing 49
Hangzhou 46
Nürnberg 46
Seoul 45
Washington 41
Taiyuan 37
Taizhou 33
Guangzhou 31
Norwalk 26
Seattle 24
Mestre 22
Düsseldorf 19
Lanzhou 19
Fuzhou 17
Redwood City 17
San Francisco 17
Toronto 16
Dearborn 15
Fairfield 15
Bologna 14
Los Angeles 14
Auburn Hills 13
San Diego 13
Boydton 12
Falls Church 12
Dongguan 10
London 10
Tappahannock 10
Cagliari 8
Bonndorf 7
Chicago 7
Clearwater 7
Melbourne 7
Tehran 7
Augusta 6
Detroit 6
Trento 6
Adelaide 5
Amsterdam 5
Costa Mesa 5
Kochi 5
Leawood 5
Paris 5
Rome 5
Saint Petersburg 5
Stockholm 5
Bangalore 4
Berlin 4
Bussolengo 4
Chang-hua 4
Dallas 4
Dubai 4
Hong Kong 4
Mexico City 4
Miami 4
Phoenix 4
Shanghai 4
Singapore 4
São Paulo 4
Tokyo 4
Borgo Valsugana 3
Boston 3
Cairo 3
Cambridge 3
Canberra 3
Columbus 3
Copenhagen 3
Cuneo 3
Totale 13.125
Nome #
Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage 197
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 175
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 166
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation 148
11 Beta-Hydroxysteroid Dehydrogenase Type2 Promoter Polymorphisms Determines a Decreased HSD11B2 Expression in Vivo 134
Novel serum paraoxonase activity assays are associated with coronary artery disease 128
11beta-hydroxysteroid dehydrogenase type 2 promoter methylation is increased in adults essential hypertensive patients 125
Array-based genome-wide DNA methylation profiles and gene expression analyses show novel regulatory pathways in alcohol-related hepatocellular carcinoma 122
11beta-hydroxysteroid dehydrogenase type2 promoter methylation is increased in adults essential hypertensive patients 120
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 119
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 115
Genome-wide DNA methylation and gene expression profiles analysis show novel regulatory pathways in alcohol-related hepatocellular carcinoma 114
Nutrition and Epigenetics 112
Vitamin B-12 deficiency affects DNA synthesis and methylation 111
The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study 111
Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate 111
DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma 109
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease. 108
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 107
High ferritin and low folate increases PBMCs genomic DNA methylation in association with SHMT1-1420TT variant. 105
A1298C methylentetrahydrofolate reductase mutation and coronary artery disease:relationship with C677T polymorphysm and homocystein/folate metabolism 104
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 103
Antioxidants and hypertension. 102
The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers 102
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 101
Post-methionine loading hyperhomocysteinemia in patients with angiographically documented coronary artery disease 100
Homocysteine and atheromatous renal artery stenosis 99
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 99
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 98
A challenging case of abdominal pain associated to Helicobacter pylori infection 98
Interactions between folate and aging for carcinogenesis. 97
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 96
A genetic risk factor for vascular disease which leads to mild hyperhomocysteinemia is common in northern Italy. 96
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 95
Cardiovascular epigenetics: from DNA methylation to microRNAs 95
The MTHFD1 1958G > A Relates to Survival Rate According to PBMCs DNA Global Methylation in Cancer 94
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 93
The potential cocarcinogenic effect of vitamin B12 deficiency 93
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 93
Effects of the interaction between folate status and MTHFR 677C-T polymorphism on genomic DNA methylation 92
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 92
Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension 92
Efficacy of tacrolimus ointment in nickel sulphate allergic contact dermatitis 91
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 91
Interactions between folate and aging for carcinogenesis 89
Vitamin B6 and cardiovascular disease 89
A case of Listeria murray/grayi bacteremia in a patient with advanced Hodgking's disease 88
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 88
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 88
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 88
Methylenetetrahydrofolate reductase C677 T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. 87
Acquired form of activated protein C resistance in healthy women taking oestrogen therapy. 87
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 87
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 87
Epigenetic Regulation Of Hepcidin Expression In Non-Viral Hepatocellular Carcinoma: Results Of A Genome-Wide Study 87
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 87
Activation of K+/Cl- cotransport in human erythrocytes exposed to oxidative agents 86
Alcohol and DNA methylation 85
Unexpected subacute leucoencephalopathy following intrathecal methotrexate and cytarabine administration in a patient homozygous for MTHFR 677C→T polymorphism. 85
DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis 85
Effects of the interaction between folate status and the MTHFR 677C/T polymorphism on genomic DNA methylation 84
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 84
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 84
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 84
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation 84
CpG methylation of 11betaHydroxysteroid dehydrogenase type 2 promoter is increased in adult essential hypertension. 84
Global DNA Methylation and Hydroxymethylation Differ in Hepatocellular- and Cholangio-Carcinoma and Relate to Survival Rate 84
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 84
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction 83
Genetic polymorphisms of the renin-angiotensin system and atheromatous renal artery stenosis 83
A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. 83
Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro-progestins 82
Vitamin B6-status and coronary artery disease 82
Hyperhomocysteinemia in relation to total and cardiovascular death after coronary bypass grafting. 82
Prevalence of body iron excess in the metabolic syndrome. 82
Reduced genomic DNA methylation in peripheral mononuclear cells as an index for the occurrence of cancer disease 82
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 81
Essential Trace Elements and Promoter DNA Methylation of Mineral Transporters Genes: Unravelling Novel Epigenetic Mechanisms in Human Hepatocarcinoma. 81
A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status 80
Apolipoprotein CIII,metabolic syndrome,and risk of coronary artery disease. 80
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 80
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 80
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in advanced coronary artery disease. 80
Homocysteine,traditional risk factors and impaired renal function in coronary artery disease 79
MTHFR C677T genotype-specific thresold values of folate status able to induce mild hyperhomocysteinemia. 79
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: exploring a submerged portion of the iceberg. 79
Acquired and genetic determinants of homocysteine in atheromatous renel artery stenosis with mild renal insufficiency 78
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 77
Hyperhomocysteinemia and its relationship with aging, folate and DNA methylation 76
S-adenosylmethionine increases mtDNA density and insulin sensitivity in the skeletal muscle of OLETF Rats. 76
Determinants of serum ferritin in the metabolic syndrome. 76
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 76
An unexpected explanation for exhaustion 76
Conclusions and Future Perspectives 75
Resistance to activated protein C in healthy women taking oral contraceptives 75
Vitamin B6 status and coronary artery disease 75
Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients 75
FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease 74
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 74
Aging alters global hepatic DNA hydroxymethylation in mice, as determined by a novel LC/MS-MS method 74
Totale 9.433
Categoria #
all - tutte 51.342
article - articoli 29.110
book - libri 364
conference - conferenze 17.889
curatela - curatele 0
other - altro 357
patent - brevetti 193
selected - selezionate 0
volume - volumi 3.429
Totale 102.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019151 0 0 0 0 0 0 0 0 0 51 23 77
2019/20202.227 309 31 27 227 208 289 209 237 122 240 58 270
2020/20212.251 188 387 73 215 235 229 56 195 186 45 224 218
2021/20221.807 122 406 33 136 104 57 34 110 83 70 173 479
2022/20234.163 308 384 407 771 395 979 34 276 451 18 86 54
2023/20241.716 92 174 165 204 278 440 71 187 27 78 0 0
Totale 17.920